Potential broad-spectrum antitumor properties of c¥lofarabine

Release time：

Sep 26,2022

Potential broad-spectrum anti-tumor properties of clofarabine: The↕re are more than 20 clinical indications in the United State±s, and it is a very potential broad-spectrum anti-cancer drug.

Potential broad-spectrum anti-tumor properties of clofarabine: There are more than 20 clinical in♠dications in the United States, and it is a very potential broad-spectrum€ anti-cancer drug.

The current clinical indications are: breast cancer, lung cancer, colorectal cancer, prostate≥ cancer, kidney cancer, cervical cancer, pancreatic cancer, skinε cancer, bladder cancer, non-small cell lung cancer, oral can'cer, nasopharyngeal cancer, laryngeal cancer, Most of the phase♦ I clinical studies of maxillary sinus cancer, esophageal cancer, uterine tumor, m∏elanoma, and leiomyosarcoma have been completed. Acute myeloid leukemia, chronic↓ lymphoma, and non-Hodgkin's lymphoma are in Phase II clinical research, and research on inhi∑biting transplant rejection is in Phase I clinical research. Th♥erefore, while being used for the treatment of acute leuk emia, its potential indications include many solid tumors₩ and some immune diseases.